Study of Pembrolizumab With or Without Defactinib Following Chemotherapy as a Neoadjuvant and Adjuvant Treatment for Resectable Pancreatic Ductal Adenocarcinoma
Clinical trial NCT03727880 · COMPLETED
Trial details
- NCT number
- NCT03727880
- Sponsor
- Lei Zheng
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-04
- Primary completion
- 2025-01-15
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.